DE69325408D1 - Pharmazeutische Zubereitung in wässriger Suspensionsform - Google Patents
Pharmazeutische Zubereitung in wässriger SuspensionsformInfo
- Publication number
- DE69325408D1 DE69325408D1 DE69325408T DE69325408T DE69325408D1 DE 69325408 D1 DE69325408 D1 DE 69325408D1 DE 69325408 T DE69325408 T DE 69325408T DE 69325408 T DE69325408 T DE 69325408T DE 69325408 D1 DE69325408 D1 DE 69325408D1
- Authority
- DE
- Germany
- Prior art keywords
- aqueous suspension
- pharmaceutical preparation
- suspension form
- pharmaceutical
- aqueous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP08108392A JP3207494B2 (ja) | 1992-04-02 | 1992-04-02 | 水性懸濁製剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69325408D1 true DE69325408D1 (de) | 1999-07-29 |
DE69325408T2 DE69325408T2 (de) | 1999-10-21 |
Family
ID=13736499
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69325408T Expired - Fee Related DE69325408T2 (de) | 1992-04-02 | 1993-03-24 | Pharmazeutische Zubereitung in wässriger Suspensionsform |
Country Status (4)
Country | Link |
---|---|
US (1) | US5334378A (de) |
EP (1) | EP0564154B1 (de) |
JP (1) | JP3207494B2 (de) |
DE (1) | DE69325408T2 (de) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5980882A (en) * | 1997-04-16 | 1999-11-09 | Medeva Pharmaceuticals Manufacturing | Drug-resin complexes stabilized by chelating agents |
SE9702793D0 (sv) | 1997-07-24 | 1997-07-24 | Astra Pharma Prod | Novel formulation |
WO2002040034A1 (en) * | 2000-11-14 | 2002-05-23 | Vital Health Sciences Pty Ltd. | Complexes of phosphate derivatives |
AUPR549901A0 (en) * | 2001-06-06 | 2001-07-12 | Vital Health Sciences Pty Ltd | Topical formulation containing tocopheryl phosphates |
US20030068276A1 (en) * | 2001-09-17 | 2003-04-10 | Lyn Hughes | Dosage forms |
US20040126428A1 (en) * | 2001-11-02 | 2004-07-01 | Lyn Hughes | Pharmaceutical formulation including a resinate and an aversive agent |
DE10224086A1 (de) * | 2002-05-31 | 2003-12-11 | Bayer Ag | Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker |
AU2002950713A0 (en) * | 2002-08-09 | 2002-09-12 | Vital Health Sciences Pty Ltd | Carrier |
CA2557354C (en) * | 2004-03-03 | 2013-05-07 | Vital Health Sciences Pty Ltd. | Alkaloid formulations |
US20050265955A1 (en) * | 2004-05-28 | 2005-12-01 | Mallinckrodt Inc. | Sustained release preparations |
EP2269650A3 (de) * | 2004-08-03 | 2012-05-16 | Vital Health Sciences Pty Ltd. | Träger zur enteralen Verabreichung |
WO2006092024A1 (en) * | 2005-03-03 | 2006-09-08 | Vital Health Sciences Pty Ltd | Compounds having anti-cancer properties |
US20090239827A1 (en) * | 2005-03-03 | 2009-09-24 | Esra Ogru | Compounds having lipid lowering properties |
JP2008543751A (ja) * | 2005-06-09 | 2008-12-04 | ユーピーエム ファルマセウチカルス インコーポレーテッド | 易水溶性電解質薬物のための水性徐放性薬物送達システム |
NZ565049A (en) | 2005-06-17 | 2012-02-24 | Vital Health Sciences Pty Ltd | A carrier comprising one or more DI and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof |
KR101495146B1 (ko) | 2006-03-16 | 2015-02-24 | 트리스 파마 인코포레이티드 | 약물 - 이온교환 수지 복합체를 함유하는 변형 방출 제제 |
BRPI0621872A2 (pt) * | 2006-07-19 | 2012-10-16 | Universidad De Guadalajara | métodos para preparar um fármaco em suspensão e em cápsulas para uso pediátrico e para adulto a base de curcumina, formulação e fármacos em suspensão e em cápsulas para o tratamento de uma infecção parasitária causada por giárdia lamblia e métodos para tratar um infecção parasitária provocada por giárdia lamblia |
JP2010510320A (ja) | 2006-11-21 | 2010-04-02 | マクニール−ピーピーシー・インコーポレーテツド | 改変型放出鎮痛性懸濁液 |
WO2008151071A1 (en) * | 2007-05-30 | 2008-12-11 | Neos Therapeutics, Lp | Modifying drug release in suspensions of ionic resin systems |
US9833510B2 (en) | 2007-06-12 | 2017-12-05 | Johnson & Johnson Consumer Inc. | Modified release solid or semi-solid dosage forms |
EP2531047A4 (de) | 2010-02-05 | 2014-03-19 | Phosphagenics Ltd | Träger mit einem nichtneutralisierten tocopherylphosphat |
EP2552486B1 (de) | 2010-03-30 | 2020-08-12 | Phosphagenics Limited | Pflaster für transdermale verabreichung |
ES2588008T3 (es) * | 2010-05-19 | 2016-10-28 | Astellas Pharma Inc. | Composición farmacéutica que contiene solifenacina |
US9561243B2 (en) | 2011-03-15 | 2017-02-07 | Phosphagenics Limited | Composition comprising non-neutralised tocol phosphate and a vitamin A compound |
ES2441468B1 (es) | 2012-08-03 | 2014-11-13 | Laboratorios Rubió, S.A. | Composición farmacéutica sólida de resina de intercambio catiónico. |
US11590228B1 (en) | 2015-09-08 | 2023-02-28 | Tris Pharma, Inc | Extended release amphetamine compositions |
JP6882321B2 (ja) | 2015-12-09 | 2021-06-02 | フォスファージニクス リミテッド | 医薬製剤 |
AU2017381395A1 (en) | 2016-12-21 | 2019-06-20 | Phosphagenics Limited | Process |
US11590081B1 (en) | 2017-09-24 | 2023-02-28 | Tris Pharma, Inc | Extended release amphetamine tablets |
JPWO2019240290A1 (ja) * | 2018-06-16 | 2021-06-24 | ロート製薬株式会社 | 外用組成物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2697059A (en) * | 1951-01-22 | 1954-12-14 | Edwin L Gustus | Hydroxy aromatic carboxylate-resin adsorption composition |
FR806M (de) * | 1960-08-31 | 1960-09-18 | ||
IL90245A (en) * | 1988-05-11 | 1994-04-12 | Glaxo Group Ltd | Resin adsorption containing ranitidine together with synthetic resin replaces cations, its preparation and pharmaceutical preparations containing it |
US5188825A (en) * | 1989-12-28 | 1993-02-23 | Iles Martin C | Freeze-dried dosage forms and methods for preparing the same |
-
1992
- 1992-04-02 JP JP08108392A patent/JP3207494B2/ja not_active Expired - Fee Related
-
1993
- 1993-03-24 EP EP93302257A patent/EP0564154B1/de not_active Expired - Lifetime
- 1993-03-24 DE DE69325408T patent/DE69325408T2/de not_active Expired - Fee Related
- 1993-03-26 US US08/037,360 patent/US5334378A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0564154B1 (de) | 1999-06-23 |
DE69325408T2 (de) | 1999-10-21 |
JP3207494B2 (ja) | 2001-09-10 |
US5334378A (en) | 1994-08-02 |
JPH05279246A (ja) | 1993-10-26 |
EP0564154A1 (de) | 1993-10-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69325408D1 (de) | Pharmazeutische Zubereitung in wässriger Suspensionsform | |
DK0515312T3 (da) | Farmaceutisk præparat | |
DK0539319T3 (da) | Farmaceutisk cyclosporinpræparat | |
DE69525148T2 (de) | Pharmazeutische formulierung | |
ATE203400T1 (de) | Pharmazeutische formulierungen | |
DE10199066I1 (de) | Pharmazeutische Zusammensetzung | |
NO922005D0 (no) | Farmasoeytiske preparater | |
DK481989D0 (da) | Farmaceutiske formuleringer | |
DK489189D0 (da) | Farmaceutisk praeparat | |
ATA154489A (de) | Feste pharmazeutische ranitidinpraeparate | |
FI930882A0 (fi) | Farmaceutiska foereningar | |
DE122006000065I2 (de) | Cephalosporine und ihre Homologen, Zubereitungen und pharmazeutische Pr{parate | |
DE4294862T1 (de) | Pharmazeutische Komposition | |
DE59310248D1 (de) | Pharmazeutische Zubereitung auf Gestagen-Basis | |
FI931251A (fi) | Farmaceutiska foereningar | |
DE69300017T2 (de) | Wässrige pharmazeutische Zubereitung von Natriumcromoglykat. | |
DK603988D0 (da) | Farmaceutisk praeparat | |
DK496889D0 (da) | Peptidholdigt farmaceutisk praeparat | |
DK336489A (da) | Farmaceutisk praeparat | |
DE69122229T2 (de) | Penciclovir enthaltende pharmazeutische formulierung | |
DE58905160D1 (de) | Pharmazeutische zubereitung. | |
NO942228D0 (no) | Ipsapiron-legemiddeltilberedning | |
DK638889D0 (da) | Farmaceutisk kombinationspraeparat | |
ATA77096A (de) | Pharmazeutische präparation | |
DK204190D0 (da) | Farmaceutisk praeparat |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |